Blood pressure medication recall continues to expand

A recall on blood pressure medication first announced in April has been expanded. Teva Pharmaceuticals USA Inc. issued a voluntary recall for losartan potassium tablets that may contain N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) at levels higher than the FDA's acceptable exposure limit. NMBA, which has been shown to cause cancer in rats, qualifies as a known animal carcinogen and a potential human carcinogen. The expanded recall involves six lots of bulk losartan potassium USP tablets...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports